Mosliciguat

mosliciguat · Pulmovant, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Mosliciguat, covering 2025-09-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD [Phase 2]